Dear Researchers,

The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Bege Miklós

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2015-2026

2026

Petróczi, D. F., Tótik, A., Bege, M., Király, J., Szabó, E., Szabó, Z., Dobos, N., Kattoub, R. G., Upadhyay, C., Ostorházi, E., Hodek, J., Weber, J., Arany, J., Ádám, D., Zouboulis, C. C., Oláh, A., Bajza, I., Tósaki, Á., Halmos, G., Rathi, B., Herczegh, P., Borbás, A., Bereczki, I.: Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agents.
J Cannabis Res. [Epub ahead of print], 2026.

doi DEA

Journal metrics:

Q1 Complementary and Alternative Medicine (2025)

Q1 Health (social science) (2025)

Q2 Pharmacology (2025)

Q2 Pharmacology (medical) (2025)

Bege, M., Lovas, M., Borbás, A.: From Concept to Clinic: vepdegestrant (ARV 471) Becomes the First Approved PROTAC Drug.
Pharmaceutics. 18 (7), 1-19, (article identifier: 827), 2026.

doi DEA

Journal metrics:

D1 Pharmaceutical Science (2025)

2025

Bege, M., Kattoub, R. G., Borbás, A.: Avacincaptad pegol, the second approved aptamer medicine: a mini review.
DRem. 1 (2), 29-45, 2025.

doi DEA

Bege, M., Borbás, A.: New anticancer medicines approved by the EMA in 2024.
DRem. 1 (2), 46-56, 2025.

doi DEA

Kelemen, V., Bege, M., Debreczeni, N., Bereczki, I., Bényei, A., Herczegh, P., Borbás, A.: Stereoselective Synthesis of 1,2-cis-alpha-Glycosyl Thiols and Trehalose-Type alpha,alpha'-Thiodisaccharides by Cryo Thiol-Ene Photocoupling - Thio-Click Reaction in Frozen State.
Chem.-Eur. J. 31 (20), (article identifier: 202500104), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q2 Chemistry (miscellaneous)

Q1 Organic Chemistry

Bege, M., Lovas, M., Priksz, D., Bernát, B., Bereczki, I., Kattoub, R. G., Kajtár, R., Eskeif, S., Novák, L., Hodek, J., Weber, J., Herczegh, P., Lekli, I., Borbás, A.: Synthesis, H2S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5'-dithioacetates.
Sci Rep. 15 (1), 2876-2881, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary

Bege, M., Leiner, K., Lovas, M., Pető, R., Bereczki, I., Hodek, J., Weber, J., Kuczmog, A., Borbás, A.: Synthesis of 3'-modified xylofuranosyl nucleosides bearing 5'-silyl or -butyryl groups and their antiviral effect against RNA viruses.
Eur. J. Pharm. Sci. 209, 1-12, (article identifier: 107107), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

Bege, M., Kattoub, R. G., Borbás, A.: The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: history, Recent Advances and Future Prospects of Aptamers in Therapy.
Pharmaceutics. 17 (3), 394-, 2025.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

2024

Bege, M., Borbás, A.: Medicines for influencing the posttranslational modifications of histones - a tutorial review.
DRem. 1 (1), 1-13, 2024.

doi DEA

10.

Bege, M., Borbás, A.: The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19.
Pharmaceutics. 16 (2), 1-17, (article identifier: 217), 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science

11.

Óvári, I., Viczján, G., Bege, M., Borbás, A., Herczegh, P., Zsuga, J., Papp, Z., Szilvássy, Z., Juhász, B., Gesztelyi, R., Erdei, T. D.: The ex vivo effects of hypoxanthine-tricyclano, a synthetic adenosine analogue, on rat left and right atria.
Gen. Physiol. Biophys. 43 (6), 577-584, 2024.

doi DEA Scopus

Journal metrics:

Q3 Biophysics

Q3 Medicine (miscellaneous)

Q4 Physiology

2023

12.

Godoy, A. S., Nakamura, A. M., Douangamath, A., Song, Y., Noske, G. D., Gawriljuk, V. O., Fernandes, R. S., Pereira, H. D. M., Oliveira, K. I. Z., Fearon, D., Dias, A., Krojer, T., Fairhead, M., Powell, A., Dunnet, L., Brandao-Neto, J., Skyner, R., Chalk, R., Bajusz, D., Bege, M., Borbás, A., Keserű, G. M., Delft, F. v., Oliva, G.: Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease.
Nucleic Acids Res. 51 (10), 5255-5270, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Genetics

13.

Bege, M., Singh, V., Sharma, N., Debreczeni, N., Bereczki, I., Herczegh, P., Rathi, B., Singh, S., Borbás, A.: In vitro and in vivo antiplasmodial evaluation of sugar-modified nucleoside analogues.
Sci. Rep. 13 (1), 1-8, (article identifier: 12228), 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

14.

Debreczeni, N., Hotzi, J., Bege, M., Lovas, M., Mező, E., Bereczki, I., Herczegh, P., Kiss, L., Borbás, A.: N-Fluoroalkylated Morpholinos - a New Class of Nucleoside Analogues.
Chem.-Eur. J. 29 (11), 1-16, (article identifier: 202203248), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Chemistry (miscellaneous)

Q1 Organic Chemistry

15.

Bege, M., Herczeg, M., Bereczki, I., Debreczeni, N., Bényei, A., Herczegh, P., Borbás, A.: Triaza-tricyclanos - synthesis of a new class of tricyclic nucleoside analogues by stereoselective cascade cyclocondensation.
Org. Biomol. Chem. 21 (10), 2213-2219, 2023.

doi DEA WoS Scopus

Journal metrics:

Q3 Biochemistry

Q2 Organic Chemistry

Q2 Physical and Theoretical Chemistry

2022

16.

Óvári, I., Szilágyi, V., Viczján, G., Lampé, N., Bege, M., Borbás, A., Herczeg, P., Juhász, B., Gesztelyi, R., Erdei, T. D.: Egy újonnan szintetizált adenozin analóg, a hipoxantin-triciklánó hatása izolált patkány bal és jobb pitvaron.
Eü. Innov. Szle. 1 (1), 9-16, 2022.

DEA

17.

Bege, M., Borbás, A.: Rise and fall of fomivirsen, the first approved gene silencing medicine: a historical review.
Acta Pharm Hung. 92 (1), 38-44, 2022.

doi DEA

18.

Bege, M., Kiss, A., Bereczki, I., Hodek, J., Polyák, L., Szemán-Nagy, G., Naesens, L., Weber, J., Borbás, A.: Synthesis and Anticancer and Antiviral Activities of C-2'-Branched Arabinonucleosides.
Int. J. Mol. Sci. 23 (20), 1-24, (article identifier: 12566), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

19.

Bege, M., Borbás, A.: The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides.
Pharmaceuticals (Basel). 15 (8), 1-39, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

2021

20.

Lőrincz, V., Laczkó, L., Polyák, L., Bege, M., Borbás, A., Baksa, V., Szemán-Nagy, G., Kiss, A.: Metotrexát és az N-153 nukleozid analóg tumorellenes hatásának összehasonlítása MTT teszt és time-lapse mikroszkópia segítségével.
In: Sántha Kálmán Tudományos Kerekasztal : Absztraktkötet 2020/2021. Szerk.: Matolay Orsolya, Fábián Zsófia Andrea, Debreceni Egyetem, Debrecen, 183, 2021. ISBN: 9789633189283

DEA

21.

Kiss, A., Baksa, V., Tálas, L., Bege, M., Borbás, A., Bereczki, I., Bánfalvi, G., Szemán-Nagy, G.: MTT Test and Time-lapse Microscopy to Evaluate the Antitumor Potential of Nucleoside Analogues.
Anticancer Res. 41 (1), 137-149, 2021.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Oncology

22.

Laczkó, L., Lőrincz, V., Polyák, L., Bege, M., Borbás, A., Baksa, V., Szemán-Nagy, G., Kiss, A.: Nukleozid analógok hatásainak összehasonlítása.
In: Sántha Kálmán Tudományos Kerekasztal : Absztraktkötet 2020/2021. Szerk.: Matolay Orsolya, Fábián Zsófia Andrea, Debreceni Egyetem, Debrecen, 181, 2021. ISBN: 9789633189283

DEA

23.

Debreczeni, N., Bege, M., Borbás, A.: Synthesis of Potential Glycosyl Transferase Inhibitors by Thio-Click Reactions.
Eur. J. Org. Chem. 2021 (48), 6743-6747, 2021.

doi DEA

Journal metrics:

Q2 Organic Chemistry

Q2 Physical and Theoretical Chemistry

24.

Le Thai, S., Páll, D., Rőth, E., Tran, T., Debreczeni, N., Bege, M., Bereczki, I., Ostorházi, E., Milánkovits, M., Herczegh, P., Borbás, A., Csávás, M.: The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions: synthesis and Antibacterial Studies.
Pharmaceutics. 13 (12), 1-21, (article identifier: 2028), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

25.

Debreczeni, N., Bege, M., Herczeg, M., Bereczki, I., Batta, G., Herczegh, P., Borbás, A.: Tightly linked morpholino-nucleoside chimeras: new, compact cationic oligonucleotide analogues.
Org. Biomol. Chem. 19, 8711-8721, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry